CTX-2026

Tax included
CTX-2026 is a fully human antibody that binds to CD277. CTX-2026 shows an anti-tumor effect on ovarian tumor models. CTX-2026 can be used for the research of cancer.
MedChemExpress 
HY-P99179

Data sheet

Size
Multiple sizes
Reactivity
Others
Application
Cancer-programmed cell death